Longterm safety and efficacy of subcutaneous tocilizumab monotherapy: Results from the 2-year open-label extension of the MUSASHI study

Atsushi Ogata, Koichi Amano, Hiroaki Dobashi, Masayuki Inoo, Tomonori Ishii, Tsuyoshi Kasama, Shinichi Kawai, Atsushi Kawakami, Tatsuya Koike, Hisaaki Miyahara, Toshiaki Miyamoto, Yasuhiko Munakata, Akira Murasawa, Norihiro Nishimoto, Noriyoshi Ogawa, Tomohiro Ojima, Hajime Sano, Kenrin Shi, Eisuke Shono, Eiichi SuematsuHiroki Takahashi, Yoshiya Tanaka, Hiroshi Tsukamoto, Akira Nomura

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Longterm safety and efficacy of subcutaneous tocilizumab monotherapy: Results from the 2-year open-label extension of the MUSASHI study'. Together they form a unique fingerprint.

Medicine & Life Sciences